LE WE PMID CA
Prasugrel3216Prasugrel

AJW200

ALX 0081

ARC1779

Atherothrombosis

Cangrelor

Clopidogrel

Elinogrel

Heart (Coronary heart disease BASKET)

P2Y12

PAR1

Platelets (Therapeutic inhibitors)

Prasugrel

Terutroban

Ticagrelor

Ticlopidine

Von Willebrand s factor

2010  
1
What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.
[20211848] QJM 103(6): 367-77 (2010)
2008  
2
Will prasugrel supersede clopidogrel for acute coronary syndromes?
[18393737] Med J Aust 188(7): 381-2 (2008)
2007  
3
Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile.
[18078435] Cardiovasc Drug Rev 25(4): 357-74 (2007)
2009  
4
Prasugrel: a novel platelet ADP P2Y receptor antagonist.
[19689619] Cardiovasc Ther 27(3): 194-8 (2009)
2009  
5
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
[19898643] Vasc Health Risk Manag 5(-): 873-82 (2009)
2009  
6
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel.
[19475783] Vasc Health Risk Manag 5(1): 475-81 (2009)
2009  
7
Prasugrel for the treatment of patients with acute coronary syndrome.
[19436677] Vasc Health Risk Manag 5(1): 321-4 (2009)
2009  
8
Review of prasugrel for the secondary prevention of atherothrombosis.
[19496635] J Manag Care Pharm 15(5): 383-95 (2009)
2009  
9
Critical review of prasugrel for formulary decision makers.
[19422273] J Manag Care Pharm 15(4): 335-43 (2009)
2010  
10
2008  
11
Acute coronary syndromes and diabetes mellitus: a winning ticket for prasugrel.
[18852375] Circulation 118(16): 1607-8 (2008)
2009  
12
P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.
[19633016] Eur Heart J 30(16): 1964-77 (2009)
2010  
13
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.
[20050853] Br J Pharmacol 159(3): 502-17 (2010)
2010  
14
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention.
[20507801] Health Technol Assess 14 Suppl 1(-): 31-8 (2010)
2009  
15
Pharmacy benefit spending poised to increase for antithrombotic drug therapy -- prasugrel versus clopidogrel.
[19496638] J Manag Care Pharm 15(5): 414-6 (2009)
PMC   
16
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
[C3860827] Indian Heart J 65(2):226-8 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: prasugrel

  • Prasugrel

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia